Impact of a physician-led exercise programme on quality of life, muscle mass and clinical response in inflammatory bowel disease patients during induction with disease-modifying therapy: a study protocol
Introduction Biologic and small-molecule therapies have revolutionised the treatment of moderate-to-severe inflammatory bowel disease (IBD).A significant proportion of patients experience early or delayed treatment failure.Patients with IBD with greater visceral obesity are less likely to respond to biologics.Sarcopenia has been identified as a pre